Researcher
Diederik De Cock
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Nov 2021 → 31 May 2022 - Skeletal Biology and Engineering Research Center (Division)
Member
From1 Apr 2013 → 31 Oct 2021
Projects
1 - 1 of 1
- The Future of Early Rheumatoid Arthritis Management: From Disease Control to Patient WellbeingFrom1 Oct 2018 → 31 Oct 2021Funding: FWO fellowships
Publications
41 - 50 of 76
- BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN A REAL-WORLD SETTING IN THE UNITED KINGDOM(2017)
Authors: Diederik De Cock, Lianne Kearsley-Fleet, Eileen Baildam, Michael W Beresford, Helen E Foster, Taunton R Southwood, Wendy Thomson, Kimme L Hyrich
Pages: 16 - 16 - SUSTAINED EFFECTIVENESS OF METHOTREXATE WITH STEP-DOWN GLUCOCORTICOID REMISSION INDUCTION (COBRA SLIM) FOR EARLY RHEUMATOID ARTHRITIS IN A TREAT-TO- TARGET SETTING: 2-YEAR RESULTS OF THE CARERA TRIAL(2017)
Authors: Veerle Stouten, J Joly, Diederik De Cock, Sofia Pazmiño Lucio, K Van der Elst, R Westhovens, P Verschueren
Pages: 147 - 147 - BIOSIMILARS IN THE UNITED KINGDOM: FIRST REAL-WORLD DATA FROM THE BRITISH SOCIETY FOR RHEUMATOLOGY BIOLOGICS REGISTERS FOR RHEUMATOID ARTHRITIS(2017)
Authors: Diederik De Cock, Kath Watson, Kimme L Hyrich
Pages: 140 - 140 - Pregnancy outcomes in women with rheumatoid arthritis ever treated with rituximab(2017)
Authors: Diederik De Cock, Lucy Birmingham, Kath D Watson, Lianne Kearsley-Fleet, Deborah P Symmons, Kimme L Hyrich
Pages: 661 - 663 - TREATMENT DECISIONS FOLLOWING A DIAGNOSIS OF CANCER DURING TUMUOR NECROSIS FACTOR INHIBITOR TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS(2017)
Authors: Katie L Druce, Diederik De Cock, Kath Watson, Deborah PM Symmons, Kimme L Hyrich
Pages: 68 - 68 - Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial(2017)
Authors: Patrick Verschueren, Diederik De Cock, Kristien Van der Elst, Rene Westhovens
Pages: 511 - 520 - Unraveling patient-preferred health and treatment outcomes in early rheumatoid arthritis: A longitudinal qualitative study(2016)
Authors: Kristien Van der Elst, Sabrina Meyfroidt, Diederik De Cock, An De Groef, Philip Moons, Patrick Verschueren, Rene Westhovens
Pages: 1278 - 1287 - DOES BMI INCREASE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WHEN TREATED WITH SHORT-TERM GLUCOCORTICOID REMISSION INDUCTION SCHEMES?(2016)
Authors: Diederik De Cock, R Westhovens, V Stouten, K Van der Elst, J Joly, Patrick Verschueren
Pages: 1241 - 1242 - A COST-EFFECTIVENESS ANALYSIS OF DIFFERENT INTENSIVE COMBINATION THERAPIES FOR EARLY RHEUMATOID ARTHRITIS: 1 YEAR RESULTS OF THE CARERA TRIAL(2016)
Authors: Diederik De Cock, A De Saedeleer, K Van der Elst, V Stouten, J Joly, R Westhovens, Patrick Verschueren
Pages: 121 - 121 - TRANSLATION AND VALIDATION OF THE FLEMISH VERSION OF THE BRITISH DELAY QUESTIONNAIRE TO MEASURE HELP-SEEKING BEHAVIOUR IN PATIENTS WITH NEWLY ONSET RHEUMATOID ARTHRITIS(2016)
Authors: Diederik De Cock, V Stouten, K Van der Elst, J Joly, S Smulders, A Engelen, F Devarwaere, R Westhovens, Patrick Verschueren
Pages: 1242 - 1242